ABSTRACT
OBJECTIVE: This study served to compare the degree of adrenocortical suppression following a 2-week administration of loteprednol etabonate (LE) and prednisolone acetate (PA) ophthalmic drops. PROCEDURES: In this prospective double-masked triple-crossover study, 21 clinically healthy dogs were randomized to receive loteprednol etabonate ophthalmic suspension 0.5%, prednisolone acetate ophthalmic suspension 1%, or artificial tears (AT). Each group (LE, PA, and AT) received one drop in each eye every 12 h for 2 weeks, followed by a 3-week washout period between treatment blocks. ACTH stimulation tests were performed before and after each treatment block. Serum cortisol samples were drawn before and 60 min after administration of 1 µg/kg cosyntropin IV. Repeated-measurement ANOVA followed by a Tukey's multiple comparisons test (or a Friedman test followed by a Dunn's multiple comparisons test) were used to compare pre- and post-treatment cortisol values between each group. A p-value of ≤.05 was considered significant. RESULTS: A total of 18 dogs completed the study. Prestimulation cortisol values were lower in the PA group compared to the LE (p = .0106), but not AT (p = .0589) groups, and post-stimulation cortisol values were lower in the PA group than either LE (p = .0005) or AT (p = .0002) groups. There was no significant difference detected in pre- or post-stimulation cortisol values after the treatment periods between LE and AT. CONCLUSIONS: Based on the reduced suppression of cortisol values, LE caused significantly less hypothalamic-pituitary-adrenal axis suppression than PA. A topical steroid with minimal adrenocortical suppression, such as LE, may be favorable in patients where systemic glucocorticoid effects should be avoided.
Subject(s)
Hydrocortisone , Hypothalamo-Hypophyseal System , Dogs , Animals , Loteprednol Etabonate , Prospective Studies , Cross-Over Studies , Androstadienes/adverse effects , Pituitary-Adrenal System , Ophthalmic Solutions/adverse effects , Adrenocorticotropic Hormone/pharmacologyABSTRACT
Monitoring activity level has become popular in people and animals. In the horse, these monitors may be helpful for the detection of disease, monitor limb loading after surgery, and assist in rehabilitation. The objective of this study was to evaluate the accuracy of a commercial activity monitor (AM) (FitBit Zip) in horses. In Part 1, four stalled horses had five AMs placed (head, chest, withers, and left forelimb and hindlimbs) with stride length setting of 60.96 cm and were monitored for 24 hours with AM and video. In Part 2, four stalled horses had two AMs placed (left forelimb and hindlimbs) with stride length setting of 30.48 cm and were monitored for 24 hours with AM and video. In Part 3, three horses with two AMs (left forelimb and hindlimbs) had step data collected at the walk and trot in hand by AM and video. AM and video data were compared using Pearson's correlation coefficients and by calculating AM to video step count ratios. In Part 1, there was considerable movement of AMs at the chest and withers, but head and limb mounted AMs were more secure. In Part 2, video and AM activity counts were moderate to high for forelimb and hindlimbs with R2 values of 0.82 and 0.74, respectively. From Part 3, AMs mounted on either forelimb or hindlimbs approximately doubled the step counts compared to the video. While this AM did not accurately count steps, it may be able to provide general information on activity level in the stalled horses.